194 related articles for article (PubMed ID: 12093082)
1. The differential vulnerability of striatal projection neurons in 3-nitropropionic acid-treated rats does not match that typical of adult-onset Huntington's disease.
Sun Z; Xie J; Reiner A
Exp Neurol; 2002 Jul; 176(1):55-65. PubMed ID: 12093082
[TBL] [Abstract][Full Text] [Related]
2. Relative survival of striatal projection neurons and interneurons after intrastriatal injection of quinolinic acid in rats.
Figueredo-Cardenas G; Anderson KD; Chen Q; Veenman CL; Reiner A
Exp Neurol; 1994 Sep; 129(1):37-56. PubMed ID: 7925841
[TBL] [Abstract][Full Text] [Related]
3. Transient global ischemia in rats yields striatal projection neuron and interneuron loss resembling that in Huntington's disease.
Meade CA; Figueredo-Cardenas G; Fusco F; Nowak TS; Pulsinelli WA; Reiner A
Exp Neurol; 2000 Dec; 166(2):307-23. PubMed ID: 11085896
[TBL] [Abstract][Full Text] [Related]
4. Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-akinesia.
Albin RL; Reiner A; Anderson KD; Penney JB; Young AB
Ann Neurol; 1990 Apr; 27(4):357-65. PubMed ID: 1972318
[TBL] [Abstract][Full Text] [Related]
5. Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study.
Deng YP; Albin RL; Penney JB; Young AB; Anderson KD; Reiner A
J Chem Neuroanat; 2004 Jun; 27(3):143-64. PubMed ID: 15183201
[TBL] [Abstract][Full Text] [Related]
6. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid.
Guyot MC; Hantraye P; Dolan R; Palfi S; Maziére M; Brouillet E
Neuroscience; 1997 Jul; 79(1):45-56. PubMed ID: 9178864
[TBL] [Abstract][Full Text] [Related]
7. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid.
Beal MF; Brouillet E; Jenkins BG; Ferrante RJ; Kowall NW; Miller JM; Storey E; Srivastava R; Rosen BR; Hyman BT
J Neurosci; 1993 Oct; 13(10):4181-92. PubMed ID: 7692009
[TBL] [Abstract][Full Text] [Related]
8. Age-dependent differences in survival of striatal somatostatin-NPY-NADPH-diaphorase-containing interneurons versus striatal projection neurons after intrastriatal injection of quinolinic acid in rats.
Figueredo-Cardenas G; Chen Q; Reiner A
Exp Neurol; 1997 Aug; 146(2):444-57. PubMed ID: 9270055
[TBL] [Abstract][Full Text] [Related]
9. Corticostriatopallidal neuroprotection by adenovirus-mediated ciliary neurotrophic factor gene transfer in a rat model of progressive striatal degeneration.
Mittoux V; Ouary S; Monville C; Lisovoski F; Poyot T; Conde F; Escartin C; Robichon R; Brouillet E; Peschanski M; Hantraye P
J Neurosci; 2002 Jun; 22(11):4478-86. PubMed ID: 12040055
[TBL] [Abstract][Full Text] [Related]
10. Topological analysis of striatal lesions induced by 3-nitropropionic acid in the Lewis rat.
Blum D; Gall D; Cuvelier L; Schiffmann SN
Neuroreport; 2001 Jun; 12(8):1769-72. PubMed ID: 11409756
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of suicide transport lesions of the striatonigral or striatopallidal pathways on subsets of striatal neurons.
Roberts RC; Harrison MB; Francis SM; Wiley RG
Exp Neurol; 1993 Dec; 124(2):242-52. PubMed ID: 7507060
[TBL] [Abstract][Full Text] [Related]
12. Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease.
Albin RL; Reiner A; Anderson KD; Dure LS; Handelin B; Balfour R; Whetsell WO; Penney JB; Young AB
Ann Neurol; 1992 Apr; 31(4):425-30. PubMed ID: 1375014
[TBL] [Abstract][Full Text] [Related]
13. Differential loss of striatal projection neurons in Huntington disease.
Reiner A; Albin RL; Anderson KD; D'Amato CJ; Penney JB; Young AB
Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5733-7. PubMed ID: 2456581
[TBL] [Abstract][Full Text] [Related]
14. Astrocytes from cortex and striatum show differential responses to mitochondrial toxin and BDNF: implications for protection of striatal neurons expressing mutant huntingtin.
Saba J; López Couselo F; Turati J; Carniglia L; Durand D; de Laurentiis A; Lasaga M; Caruso C
J Neuroinflammation; 2020 Oct; 17(1):290. PubMed ID: 33023623
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial toxin 3-nitropropionic acid produces startle reflex abnormalities and striatal damage in rats that model some features of Huntington's disease.
Kodsi MH; Swerdlow NR
Neurosci Lett; 1997 Aug; 231(2):103-7. PubMed ID: 9291151
[TBL] [Abstract][Full Text] [Related]
16. Chronic intoxication with 3-nitropropionic acid in rats induces the loss of striatal dopamine terminals without affecting nigral cell viability.
Blum D; Galas MC; Cuvelier L; Schiffmann SN
Neurosci Lett; 2004 Jan; 354(3):234-8. PubMed ID: 14700739
[TBL] [Abstract][Full Text] [Related]
17. Relative resistance of striatal neurons containing calbindin or parvalbumin to quinolinic acid-mediated excitotoxicity compared to other striatal neuron types.
Figueredo-Cardenas G; Harris CL; Anderson KD; Reiner A
Exp Neurol; 1998 Feb; 149(2):356-72. PubMed ID: 9500958
[TBL] [Abstract][Full Text] [Related]
18. Differential changes in striatal projection neurons in R6/2 transgenic mice for Huntington's disease.
Sun Z; Del Mar N; Meade C; Goldowitz D; Reiner A
Neurobiol Dis; 2002 Dec; 11(3):369-85. PubMed ID: 12586547
[TBL] [Abstract][Full Text] [Related]
19. Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to MPTP, malonate and 3-nitropropionic acid neurotoxicity.
Klivenyi P; Starkov AA; Calingasan NY; Gardian G; Browne SE; Yang L; Bubber P; Gibson GE; Patel MS; Beal MF
J Neurochem; 2004 Mar; 88(6):1352-60. PubMed ID: 15009635
[TBL] [Abstract][Full Text] [Related]
20. Remote microglial activation in the quinolinic acid model of Huntington's disease.
Töpper R; Gehrmann J; Schwarz M; Block F; Noth J; Kreutzberg GW
Exp Neurol; 1993 Oct; 123(2):271-83. PubMed ID: 8405289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]